Integrating RetinAI Discovery Clinics in a Real World Setting: Addressing AMD & GA

In this video, we present highlights from our breakfast session at EURETINA 2024, where we explored the cutting-edge capabilities of the RetinAI Discovery Platform.
Dr. Audre Ambresin shares her real-world experience of integrating AI into her clinic, focusing on how it enhances patient care and streamlines clinical research.
Whether you’re looking to understand AI’s impact on Age-related Macular Degeneration (AMD) and Geographic Atrophy (GA) or want a deeper dive into the practical benefits of our platform, RetinAI Discovery Clinics, this session offers valuable insights.
Key Topics Covered
How AI can transform the diagnostic and treatment journey for nAMD patients
The benefits of integrating AI for efficient GA assessments
Real-world case studies showcasing AI’s role in clinical research
Practical Q&A session addressing common queries about the RetinAI Discovery Platform
00:00 Intro
07:54 Dr. Audre Ambresin Introduction
08:38 Integrating Discovery in a Real-Life Setting
10:50 Changing the nAMD Patient Journey & Diagnostic/Treatment with AI
15:43 Planning the Integration of AI in Clinical Practice
26:57 Advancing GA Lesion Measurements with AI
31:19 Integrating AI to Facilitate Clinical Research
37:14 Automated Identification & Quantification of Biomarkers on OCTs
40:26 Conclusion: Benefits of AI in AMD-Dedicated Clinics
41:35 Q&A Session